All investigators in the field of clinical pharmacy, clinical pharmacology, and pharmacotherapy, ACCP members and nonmembers alike, are invited to submit abstracts of papers to be considered for presentation at the ACCP Global Conference on Clinical Pharmacy in San Francisco, California, October 17-21, 2015.

All abstracts accepted for poster presentation, except for “Encore” presentations, will have abstracts published online in Pharmacotherapy. “Encore” abstracts will be published full-text in the Meeting Guide. Posters from all categories will be distributed across the poster display sessions/days throughout the meeting. Poster session/day assignments will be made as early as possible, but not later than August 15, 2015.

Consult the complete submission instructions and guidelines at https://accp.confex.com/accp/2015am/cfp.cgi for further details.

SPECIAL GLOBAL CONFERENCE CATEGORIES

International Clinical Pharmacy Practice: Abstracts must describe the development, delivery, justification, or documentation of clinical pharmacy practice outside of the United States. Abstracts that describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component. The abstract must not have been published in abstract form or presented elsewhere.
Abstract Submission Deadline: February 15, 2015

International Clinical Pharmacy Education and Training: Abstracts must describe the development, delivery, or advancement of clinical pharmacy education/training outside of the United States. Abstracts may be descriptive and need not contain an evaluative component. The abstract must not have been published in abstract form or presented elsewhere.
Abstract Submission Deadline: February 15, 2015

Original Research: Abstracts must summarize hypothesis-driven research findings. Basic, clinical, translational, dissemination/implementation, or educational research are examples of acceptable research. Topics should appeal to a clinical pharmacy audience and may include research in drug metabolism, health services, education/pedagogy, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are welcome.
Abstract Submission Deadline: February 15, 2015

Clinical Pharmacy Forum: Abstracts must describe the development, delivery, justification, or documentation of innovative clinical pharmacy services. Abstracts that address components of the ACCP Standards of Practice for Clinical Pharmacists (see http://www.accp.com/standards) and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component.
Abstract Submission Deadline: February 15, 2015

Residents and Fellows Research in Progress: Submission and evaluation criteria are those of an Original Research abstract except that the research effort is ongoing. Descriptions of planned research efforts without data should not be submitted. Submission of partially completed data is acceptable.

• The presenting author must be in a post-graduate training program (PGY-1 or PGY-2 residency, Ph.D./Masters graduate degree program, or fellowship program).
• Abstracts submitted in the Resident and Fellow Research in Progress category are not eligible for the Resident and Fellow Best Paper competition. *Note: to be eligible for the Resident and Fellow Best Paper competition, the research must be complete and the abstract submitted under the Original Research category, indicating that it was conducted by a resident/fellow.

International Trainee "Early Decision" Abstract Submission Deadline: February 15, 2015
International Trainee "Late Decision" Abstract Submission Deadline: July 1, 2015
U.S. Trainee Abstract Submission Deadline: July 1, 2015

Students Research in Progress: Submission and evaluation criteria are those of an Original Research abstract except that the research effort is ongoing. Descriptions of planned research efforts without data should not be submitted. Submission of partially completed data is acceptable.

• The presenting author must be a first professional degree (Pharm.D. or BS Pharm) student.
• Abstracts submitted in the Student Research in Progress category are not eligible for the Student Best Paper competition. *Note: to be eligible for the Student Best Paper competition the research must be complete and the abstract submitted under the Original Research category, indicating that it was conducted by a student.

International Trainee "Early Decision" Abstract Submission Deadline: February 15, 2015
International Trainee "Late Decision" Abstract Submission Deadline: July 1, 2015
U.S. Trainee Abstract Submission Deadline: July 1, 2015

Encore Presentation: Submission and evaluation criteria are those of either the Original Research or Clinical Pharmacy Forum category, except that the same abstract was presented elsewhere or published in abstract form only prior to this meeting.

• Abstracts submitted for Encore Presentations must not be modified from the previously presented/published version.
• Submit Encore Presentation abstracts as either Original Research or Clinical Pharmacy Forum and select "encore" when prompted.

ACCEPTANCE NOTIFICATION DATES

• Abstracts with a February 15, 2015 submission deadline will be notified of selection by April 15, 2015
• Abstracts with a July 1, 2015 submission deadline will be notified of selection by August 15, 2015.

See complete submission instructions and guidelines at https://accp.confex.com/accp/2015am/cfp.cgi.